Innovative Perspectives of Integrated Chinese Medicine on H. pylori

Chin J Integr Med. 2018 Nov;24(11):873-880. doi: 10.1007/s11655-017-2934-6. Epub 2018 Jun 8.

Abstract

Helicobacter pylori (H. pylori) treatment requires the development of more effective therapies, mainly owing to the challenges posed by the bacterial resistance to antibiotics. In China, critically high infection and antibiotic resistance rates have limited the application of classic H. pylori eradication therapies. Consequently, researchers are attempting to find new solutions by drawing from traditional medicine. This article reviews basic scientific and clinical progress in the use of integrated Chinese and Western medicine (IM) to treat H. pylori; describes the conflicting results between in vivo and in vitro studies in this regard; discusses the observed clinical effects of IM, with emphasis on traditional patent medicines; and proposes a role for IM in both the diagnosis and treatment of H. pylori, including the use of tongue manifestation as an early diagnostic method and capitalizing on IM's direct and indirect methods for enhancing antibiotic effect.

Keywords: Helicobacter pylori; integrated traditional Chinese and Western medicine; phytomedicine.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Delivery of Health Care, Integrated
  • Drugs, Chinese Herbal / pharmacology
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy
  • Helicobacter pylori / drug effects*
  • Humans
  • Medication Adherence
  • Medicine, Chinese Traditional*

Substances

  • Drugs, Chinese Herbal